Evaluating longer term outcomes from NHS stop smoking services (ELONS)
ELONS is an observational study, funded by NIHR (National Institute for Health Research) to explore the factors that determine longer term abstinence from smoking following intervention by NHS stop smoking services (SSS) in England. The primary outcome will be biochemically validated prolonged abstinence at 12 months among smokers who have received different intervention types offered by the services, with particular emphasis on evaluating outcomes in more disadvantaged groups.
-
To examine the effectiveness of NHS stop smoking services by PCT and intervention type using routine data
-
To explore the reach of services by indentifying the proportion of the local population who set a quit date with services using routine data
-
To describe the factors that determine longer term abstinence from smoking relapse to smoking amongst clients who set a date with the services in a sample of PCT's in England
-
To examine the relationship between client characteristics (in particular socio-econmic status, age, gender, disability and ethnicity), adherence to treatment (session attendance and number of weeks pharacological products are taken) intervention type received, and longer term abstinence
-
To create an evidence base to guide delivery of interventions by stop smoking services so that these interventions will have maximal effect on smoking cessation and population health
NHS SSSs in England
Smokers who make contact with NHS SSSs in England
Existing treatment provided by SSSs is a combination of behavioural support and medication. We will focus on evaluating outcomes for smokers who receive one of the 5 main forms of behavioural support (intervention types) provided. These are: closed groups, rolling groups, one to one drop in, one to one appointments with a specialist adviser and one to one appointments with a sessional adviser.
-
Screening/Baseline Assessment (at quit date)
Enhanced monitoring form including sociodemographics and smoking behaviour
-
At 4 weeks post quit date
Self assessed abstinence and CO measurement.
Patient satisfaction questionnaire.
SSS records, including weeks of pharmacotherapy taken, session attendance and uploads to the North51 database.
-
At 52 weeks post quit date
Follow up by BMRB market research company to measure self assessed abstinence and CO measurement.